Virtus Biotech Clinical Trials ETF BBC
39.77 USD 0.00 (+0.00%)
As ofNov 19, 2026, 3:59 PM EST
39.42 Day range 40.66
33.20 52-week range 56.18
- YTD
- +3.14%
- 1 year
- +17.70%
5D -2.13 (-4.93%)
- YTD return
- +3.14%
- 1-year return
- +17.70%
- 50-day average
- 27.91
- 200-day average
- 27.48
- Volume
- 154.69K
- Avg volume
- 34.33K
- Open
- 40.51
- Previous close
- 39.77
- Day's range
- 39.42 – 40.66
- 52-week range
- 33.20 – 56.18
About Virtus Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BBC — it syncs with the Stock Master app.
